Amicus Therapeutics (FOLD)

Feb 19, 2025, 2:04 PM EST - 3 days ago

Amicus Therapeutics, Inc. (FOLD) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 7:00 AM EST - 3 days ago

Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates

Feb 17, 2025, 5:59 PM EST - 5 days ago

Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm

Feb 10, 2025, 7:00 AM EST - 12 days ago

Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025

Feb 3, 2025, 7:00 AM EST - 19 days ago

Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025

Jan 23, 2025, 3:38 PM EST - 4 weeks ago

NCLA Amicus Brief Asks Fifth Circuit to Uphold Jury-Trial Rights in FDIC Enforcement Cases

Jan 13, 2025, 1:46 PM EST - 5 weeks ago

NCLA Amicus Brief Asks Supreme Court to Keep Unlawful Corporate Transparency Act Enjoined

Jan 13, 2025, 12:56 PM EST - 5 weeks ago

3 Oversold Biotech Names

AVDL JAZZ VKTX XBI

Jan 12, 2025, 4:00 PM EST - 5 weeks ago

Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook

Jan 2, 2025, 7:00 AM EST - 7 weeks ago

Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 8:30 AM EST - 7 weeks ago

Fold, Inc. Announces Up To $30 Million Convertible Note Financing Backed by Bitcoin

Dec 27, 2024, 1:33 PM EST - 2 months ago

Amicus Therapeutics: Cheap Heading Into 2025

Dec 23, 2024, 3:43 PM EST - 2 months ago

NCLA Amicus Brief Asks Supreme Court to Read Judicial Review Statute Broadly, as Congress Wrote It

Dec 18, 2024, 1:09 PM EST - 2 months ago

NCLA Amicus Brief Asks Fifth Circuit to Uphold Block on Unconstitutional Corporate Transparency Act

Dec 13, 2024, 3:28 PM EST - 2 months ago

Retired Judges' Amicus Brief Supports Judge Newman in NCLA Suit Against Her Suspension

Dec 13, 2024, 2:10 PM EST - 2 months ago

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

IMRX

Dec 3, 2024, 1:14 PM EST - 2 months ago

NCLA Amicus Brief Asks Fifth Circuit to Overturn Banking Administration Board's Denial of Jury Trial

Nov 12, 2024, 7:04 PM EST - 3 months ago

NCLA Amicus Brief Asks Fifth Circuit to Overturn Currency Comptroller's Violation of Jury Trial Rights

Nov 6, 2024, 12:54 PM EST - 3 months ago

Amicus Therapeutics, Inc. (FOLD) Q3 2024 Earnings Call Transcript

Nov 1, 2024, 7:00 AM EDT - 4 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024

Oct 28, 2024, 7:00 AM EDT - 4 months ago

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024

Oct 21, 2024, 4:18 PM EDT - 4 months ago

American Citizens Abroad (ACA) joins amicus brief supporting voting by U.S. citizens overseas

Oct 21, 2024, 4:17 PM EDT - 4 months ago

3 Attractive Biotechs With Recent Positives

EXEL MRK TEVA XBI

Oct 18, 2024, 3:47 PM EDT - 4 months ago

Amicus: Teva Settlement Clears Revenue Path Forward For Galafold

Oct 17, 2024, 11:07 AM EDT - 4 months ago

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug

TEVA

Oct 17, 2024, 7:00 AM EDT - 4 months ago

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva

Oct 4, 2024, 7:00 AM EDT - 5 months ago

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024

Sep 29, 2024, 2:44 AM EDT - 5 months ago

'Boring' Amicus Therapeutics Is Making Progress

Sep 25, 2024, 12:46 PM EDT - 5 months ago

3 'Repeatable' Biotech Trades

DVAX GSK NTLA XBI

Sep 17, 2024, 8:00 AM EDT - 5 months ago

Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Investors to Contact the Firm

Sep 3, 2024, 7:46 AM EDT - 6 months ago

UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

Sep 3, 2024, 7:05 AM EDT - 6 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

Aug 15, 2024, 10:28 PM EDT - 6 months ago

Amicus Therapeutics: A Compelling Investment In The Rare Disease Biotech Sector

Aug 9, 2024, 9:57 AM EDT - 7 months ago

Amicus Therapeutics, Inc. (FOLD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 7 months ago

Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates

Aug 7, 2024, 8:25 PM EDT - 7 months ago

In NCLA Amicus Win, Federal Circuit Revives Lawsuit Against CDC's Illegal Eviction Moratorium

Aug 2, 2024, 6:01 PM EDT - 7 months ago

NCLA Amicus Brief in NY Case Against Trump Explains Why NY's Executive Law Violates Free Speech

Jul 24, 2024, 6:05 PM EDT - 7 months ago

In NCLA Amicus Win, Fifth Circuit Rules Against FCC's Unlawful Control of Universal Service Fund

Jul 1, 2024, 12:09 PM EDT - 8 months ago

In NCLA Amicus Win, Supreme Court Upholds Small Business's Right to Judicial Review

Jun 27, 2024, 12:01 PM EDT - 8 months ago

In NCLA Amicus Win, Supreme Court Restores Americans' Rights to Trial by Jury

Jun 26, 2024, 1:48 PM EDT - 8 months ago

In NCLA Amicus Win, Fifth Circuit Upholds Permanent Block on Treasury's Illegal State Tax Cut Ban

Jun 13, 2024, 11:55 AM EDT - 9 months ago

In NCLA Amicus Win, Supreme Court Overturns NLRB-Specific Preliminary Injunction Standard

Jun 11, 2024, 11:00 AM EDT - 9 months ago

In NCLA Amicus Win, Tenth Circuit Clears Path to Toppling Intrusive Dog Kennel Inspection Regime

Jun 5, 2024, 1:06 PM EDT - 9 months ago

In NCLA Amicus Win, Fifth Circuit Topples SEC's Unlawful Effort to Regulate Private Funds

Jun 5, 2024, 7:00 AM EDT - 9 months ago

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 2, 2024, 10:18 AM EDT - 9 months ago

3 Biotech Names Under $10 I Own

AUPH VYGR

May 20, 2024, 5:06 AM EDT - 9 months ago

Amicus Therapeutics: Too Cheap At Under $10 A Share

May 9, 2024, 3:14 PM EDT - 10 months ago

Amicus Therapeutics, Inc. (FOLD) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:00 AM EDT - 10 months ago

Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates